Visible Code-of-ethics compliance could be a useful marketing tool in US
This article was originally published in Clinica
Companies in compliance with the AdvaMed code of ethics for interactions with healthcare professionals will now be able to make capital from the fact in their corporate marketing. At the association's annual meeting in Naples, Florida, last week, the AdvaMed board of directors authorised use of a new logo that proclaims any licensed user to be an AdvaMed "Code of Ethics Supporter". Companies that self-certify that they meet the eight elements of the code will be granted a licence to display the logo on their corporate website, business cards, displays and other marketing materials.
You may also be interested in...
Oxford University/AstraZeneca’s COVID-19 vaccine cuts the spread of the virus by 60%, apart from having 70% efficacy in reducing infections in vaccinated individuals. While that is good news for their Indian partner, Serum Institute, the 90% efficacy shown in a subset due to a dosing error causes a dilemma.
After announcing positive topline Phase II results for its Alzheimer’s candidate late last year, Korea's GemVax releases additional data showing significant improvement in secondary outcomes, further raising expectations for the novel peptide drug.
The US FDA’s decision to ask on device adverse event reports whether the device involved had been serviced by a third party could help the agency as well as device makers, says Ricki Chase, compliance practice director at Lachman Consultant Services.